A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining.
Ontology highlight
ABSTRACT: Loss of p53, a transcription factor activated by cellular stress, is a frequent event in cancer. The role of p53 in tumour suppression is largely attributed to cell fate decisions. Here, we provide evidence supporting a novel role for p53 in the regulation of DNA double-strand break (DSB) repair pathway choice. 53BP1, another tumour suppressor, was initially identified as p53 Binding Protein 1, and has been shown to inhibit DNA end resection, thereby stimulating non-homologous end joining (NHEJ). Yet another tumour suppressor, BRCA1, reciprocally promotes end resection and homologous recombination (HR). Here, we show that in both human and mouse cells, the absence of p53 results in impaired 53BP1 focal recruitment to sites of DNA damage induced by ionizing radiation. This effect is largely
SUBMITTER: Moureau S
PROVIDER: S-EPMC5043586 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA